Cormedix Aktie
WKN DE: A2PF3G / ISIN: US21900C3088
|
08.04.2025 14:01:32
|
CorMedix Logs Q1 Prel. Revenue Of $39 Mln
(RTTNews) - CorMedix Inc. (CRMD), a biopharmaceutical company, Tuesday reported preliminary revenue of $39 million for the first quarter. In the previous-year quarter, the company did not receive any revenue.
CorMedix sees adjusted EBITDA, or adjusted earnings before interest, taxes, depreciation, and amortization to be more than $22.5 million for the quarter.
For the first half, the company has raised its net sales to existing purchasing customers outlook to a range of $62 million to $70 million, from $50 million - $60 million guided earlier.
Der finanzen.at Ratgeber für Aktien!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Cormedix Inc Registered Shsmehr Nachrichten
| Keine Nachrichten verfügbar. |
Analysen zu Cormedix Inc Registered Shsmehr Analysen
Aktien in diesem Artikel
| Cormedix Inc Registered Shs | 9,80 | 3,70% |
|